1. Home
  2. FOXX vs PLUR Comparison

FOXX vs PLUR Comparison

Compare FOXX & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

HOLD

Current Price

$5.15

Market Cap

34.0M

Sector

N/A

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.30

Market Cap

33.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXX
PLUR
Founded
2017
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0M
33.9M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
FOXX
PLUR
Price
$5.15
$3.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
9.0K
5.5K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.78
EPS
N/A
N/A
Revenue
N/A
$1,336,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
309.82
52 Week Low
$1.71
$2.82
52 Week High
$8.70
$7.13

Technical Indicators

Market Signals
Indicator
FOXX
PLUR
Relative Strength Index (RSI) 61.58 53.24
Support Level $4.90 $3.10
Resistance Level $5.42 $3.42
Average True Range (ATR) 0.37 0.15
MACD 0.10 0.02
Stochastic Oscillator 76.57 78.57

Price Performance

Historical Comparison
FOXX
PLUR

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: